Organigram Global (OGI) Total Current Liabilities (2018 - 2025)
Organigram Global (OGI) reported Total Current Liabilities of $91.7 million for Q3 2025, up 134.53% year-over-year from $39.1 million in Q3 2024, and up 134.53% quarter-over-quarter from $39.1 million in Q3 2024.
Organigram Global (OGI) Total Current Liabilities (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has 8 years of Total Current Liabilities data on file, last reported at $91.7 million in Q3 2025.
- Total Current Liabilities for Q3 2025 came in at $91.7 million, up 134.53% year-over-year; the trailing twelve-month figure through Sep 2025 was $91.7 million (up 134.53% YoY), and the FY2025 annual result was $91.7 million, up 133.84% from the prior year.
- Total Current Liabilities improved to $91.7 million in Q3 2025 per OGI's latest filing, from $39.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $91.7 million in Q3 2025 and troughed at $16.7 million in Q3 2023.
- A 5-year average of $38.6 million and a median of $30.1 million in 2021 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Current Liabilities tumbled 82.21% in 2021, then soared 134.53% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $21.1 million in 2021, then soared by 103.17% to $42.9 million in 2022, then slumped by 61.02% to $16.7 million in 2023, then jumped by 133.61% to $39.1 million in 2024, then soared by 134.53% to $91.7 million in 2025.
- Business Quant data shows OGI's Total Current Liabilities at $91.7 million in Q3 2025, $39.1 million in Q3 2024, and $16.7 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 91.67 Mn |
| Sep 30, 2024 | 39.09 Mn |
| Sep 30, 2023 | 16.73 Mn |
| Aug 31, 2022 | 42.93 Mn |
| Aug 31, 2021 | 21.13 Mn |
| Feb 28, 2021 | 19.86 Mn |
| Nov 30, 2020 | 78.26 Mn |
| Aug 31, 2020 | 21.64 Mn |
| May 31, 2020 | 22.57 Mn |
| Feb 29, 2020 | 111.58 Mn |
| Nov 30, 2019 | 48.97 Mn |
| Aug 31, 2019 | 33.18 Mn |
| May 31, 2019 | 25.67 Mn |
| Aug 31, 2018 | 8.59 Mn |